127 related articles for article (PubMed ID: 20980962)
21. Preservation of renal function after heart transplantation: initial single-center experience with sirolimus.
De Meester JM; Van Vlem B; Walravens M; Vanderheyden M; Verstreken S; Goethals M; Kerre N; Wellens F
Transplant Proc; 2005 May; 37(4):1835-8. PubMed ID: 15919481
[TBL] [Abstract][Full Text] [Related]
22. Cyclosporine-A-based immunosuppression and renal functional reserve in organ-transplant patients.
Kamar N; Allard J; Ader JL; Rostaing L
Transplant Proc; 2004 Mar; 36(2 Suppl):248S-250S. PubMed ID: 15041347
[TBL] [Abstract][Full Text] [Related]
23. Kidney function in cyclosporine-treated pediatric heart transplant recipients.
Laine J; Jalanko H; Leijala M; Sairanen H; Holmberg C
J Heart Lung Transplant; 1997 Dec; 16(12):1217-24. PubMed ID: 9436133
[TBL] [Abstract][Full Text] [Related]
24. Calcineurin inhibitors in heart transplantation.
Keogh A
J Heart Lung Transplant; 2004 May; 23(5 Suppl):S202-6. PubMed ID: 15093806
[TBL] [Abstract][Full Text] [Related]
25. Long-term immunosuppression with anti-CD25 monoclonal antibodies in heart transplant patients with chronic kidney disease.
Cantarovich M; Giannetti N; Routy JP; Cecere R; Barkun J
J Heart Lung Transplant; 2009 Sep; 28(9):912-8. PubMed ID: 19716044
[TBL] [Abstract][Full Text] [Related]
26. Chronic kidney disease in children following lung and heart-lung transplantation.
Benden C; Kansra S; Ridout DA; Shaw NL; Aurora P; Elliott MJ; Marks SD
Pediatr Transplant; 2009 Feb; 13(1):104-10. PubMed ID: 19087230
[TBL] [Abstract][Full Text] [Related]
27. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
[TBL] [Abstract][Full Text] [Related]
28. Experience of FK506 immune suppression in pediatric heart transplantation: a study of long-term adverse effects.
Asante-Korang A; Boyle GJ; Webber SA; Miller SA; Fricker FJ
J Heart Lung Transplant; 1996 Apr; 15(4):415-22. PubMed ID: 8732602
[TBL] [Abstract][Full Text] [Related]
29. An open-label, pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in established renal allograft recipients with moderate renal insufficiency.
Peddi VR; Jensik S; Pescovitz M; Pirsch J; Adler SH; Thistlethwaite JR; Vincenti F; Cohen DJ
Clin Transplant; 2005 Feb; 19(1):130-6. PubMed ID: 15659146
[TBL] [Abstract][Full Text] [Related]
30. Anemia is a predictor of outcome in heart transplant recipients.
Przybylowski P; Malyszko J; Malyszko J
Transplant Proc; 2009 Oct; 41(8):3228-31. PubMed ID: 19857717
[TBL] [Abstract][Full Text] [Related]
31. Chronic kidney disease--a common and serious complication after intestinal transplantation.
Herlenius G; Fägerlind M; Krantz M; Mölne J; Olausson M; Gäbel M; Friman V; Oltean M; Friman S
Transplantation; 2008 Jul; 86(1):108-13. PubMed ID: 18622286
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and risk factors of renal dysfunction after liver transplant: a single-center experience.
Dehghani SM; Derakhshan A; Taghavi SA; Gholami S; Jalaeian H; Malek-Hosseini SA
Exp Clin Transplant; 2008 Mar; 6(1):25-9. PubMed ID: 18405241
[TBL] [Abstract][Full Text] [Related]
33. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens.
DuBay D; Smith RJ; Qiu KG; Levy GA; Lilly L; Therapondos G
Liver Transpl; 2008 May; 14(5):651-9. PubMed ID: 18433069
[TBL] [Abstract][Full Text] [Related]
34. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation.
Al-Hazzouri A; Cao Q; Burns LJ; Weisdorf DJ; Majhail NS
Biol Blood Marrow Transplant; 2008 Jun; 14(6):658-63. PubMed ID: 18489991
[TBL] [Abstract][Full Text] [Related]
35. Cyclosporine-induced hypertension: evidence for maintained baroreflex circulatory control.
Lucini D; Milani RV; Ventura HO; Mehra MR; Messerli FH; Murgo JP; Regenstein F; Copley B; Malliani A; Pagani M
J Heart Lung Transplant; 1997 Jun; 16(6):615-20. PubMed ID: 9229291
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
37. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
Skalicka B; Kubanek M; Malek I; Vymetalova Y; Hoskova L; Podzimkova M; Kautzner J
J Heart Lung Transplant; 2009 Jun; 28(6):598-604. PubMed ID: 19481021
[TBL] [Abstract][Full Text] [Related]
38. Discontinuation of calcineurin inhibitors in heart transplant patients with end stage renal insufficiency as an alternative model of immunosuppression.
Jerzy S; Wierzbicki K; Kapelak B; Konstanty J; Przybyłowski P; Wójcik S; Drwiła R; Wróbel K; Piatek J
Przegl Lek; 2006; 63(12):1256-8. PubMed ID: 17642134
[TBL] [Abstract][Full Text] [Related]
39. Renal function and tubular phosphate handling in long-term cyclosporine- and tacrolimus-based immunosuppression in kidney transplantation.
Falkiewicz K; Kamińska D; Nahaczewska W; Boratyńska M; Owczarek H; Klinger M; Woźniak M; Patrzałek D; Szyber P
Transplant Proc; 2006; 38(1):119-22. PubMed ID: 16504680
[TBL] [Abstract][Full Text] [Related]
40. Effect of long-term tacrolimus immunosuppression on renal function in liver transplant recipients.
Corman SL; Coley KC; Schonder KS
Pharmacotherapy; 2006 Oct; 26(10):1433-7. PubMed ID: 16999653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
